| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 07/28/2005 | WO2005068430A1 Pyridylmethyl derivatives of 2,6-dichloroisonicotinic acid, process for production of the same, and disease controllers for agricultural and horticultural use |
| 07/28/2005 | WO2005068429A1 Derivatives of pyridine and quinoline |
| 07/28/2005 | WO2005068428A1 Method for stabilizing 4-halogenpyridines with secondary and/or tertiary amines |
| 07/28/2005 | WO2005068415A1 Phenylalanine derivative |
| 07/28/2005 | WO2005068074A2 Use of metal complex compounds comprising pyridine pryimidine or s-triazne derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acid and h2o2 |
| 07/28/2005 | WO2004108719A9 2-[2-(4-morpholino)ethylamino]pyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
| 07/28/2005 | US20050165239 admixing with one or more secondary and/or tertiary aliphatic or mixed aliphatic-aromatic amines |
| 07/28/2005 | US20050165238 carried out with a mixture of peracetic acid and hydrogen peroxide as oxidant, in the presence of methanesulphonic acid and in the absence of a catalyst |
| 07/28/2005 | US20050165235 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/28/2005 | US20050165114 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents; AP-1 activation inhibitor, NF-kappa B activation inhibitor |
| 07/28/2005 | US20050165084 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; treating coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; atorvastatin 4-(nitrooxy)butyl ester |
| 07/28/2005 | US20050165069 Statine derivatives for the treatment of Alzheimer's disease |
| 07/28/2005 | US20050165067 Aryl sulfonamides |
| 07/28/2005 | US20050165066 Antiproliferative agents |
| 07/28/2005 | US20050165062 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165051 Taxanes having a C7 carbonate substituent |
| 07/28/2005 | US20050165034 Novel heterocyclic derivatives of tripeptides and tripeptide mimetics; (+-)-2-[3-[(benzylsulfonyl)amino]-6-methyl-2-oxo-1 (2H)-pyridinyl]-N-[(4,5,6,7-tetrahydro-2H-indazole-5-yl]acetamide; anticoagulants |
| 07/28/2005 | US20050165028 e.g. 4-bromo-N-(2,3-dihydro-1,4-benzodioxin-6-yl)benzamide; analgesics, neuropathic pain, inflammation, arthritis, rheumatic diseases, inflammatory bowel disorders, eye disorders, or bladder disorders, psoriasis, wounds, burns, allergic skin, herpes simplex |
| 07/28/2005 | US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165015 Vanilloid receptor ligands and their use in treatments |
| 07/28/2005 | US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 07/28/2005 | US20050164872 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 07/28/2005 | US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164029 Reactive dendrimers |
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/28/2005 | CA2552740A1 Indolylmaleimde derivatives as pkc inhibitors |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
| 07/27/2005 | EP1557197A1 Dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
| 07/27/2005 | EP1557168A2 Biarylurea Derivatives |
| 07/27/2005 | EP1556402A2 In vivo gene silencing by chemically modified and stable sirna |
| 07/27/2005 | EP1556385A1 Heterocyclocarboxamide derivatives |
| 07/27/2005 | EP1556355A1 Inhibitors of glycogen synthase kinase 3 |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556353A1 Diaryl compounds as monoamine reuptake inhibitors |
| 07/27/2005 | EP1556352A1 Compounds capable of activating cholinergic receptors |
| 07/27/2005 | EP1556342A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 07/27/2005 | EP1556340A1 Phenylethanolamine derivatives for the treatment of respiratory diseases |
| 07/27/2005 | EP1556330A2 Phenyl compounds |
| 07/27/2005 | EP1556323A2 Metal chelates and methods of using them for time-resolved fluorescence |
| 07/27/2005 | EP1556142A2 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 07/27/2005 | EP1556029A2 Thiomolybdate analogues and uses thereof |
| 07/27/2005 | EP1165738B1 Composition and method for bleaching a substrate |
| 07/27/2005 | EP1009402B1 Compositions and use of benzamides as anti-inflammatory agents |
| 07/27/2005 | EP0986561B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/27/2005 | CN1646672A Use of metal complex compounds as oxidation catalysts |
| 07/27/2005 | CN1646492A Chain oligolactic acid thioester |
| 07/27/2005 | CN1646484A Lactic acid derivative |
| 07/27/2005 | CN1646478A 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds |
| 07/27/2005 | CN1646472A Analogous compounds of strobilurines and their use as acaricides and insecticides |
| 07/27/2005 | CN1646094A A stable pharmaceutical formulation comprising torsemide modification II |
| 07/27/2005 | CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them |
| 07/26/2005 | US6921828 Processes for the preparation of 2-aminomethlpyridines and the 2-cyanopyridines used in their preparation |
| 07/26/2005 | US6921824 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 07/26/2005 | US6921768 Cytostatic cerium compounds |
| 07/26/2005 | US6921767 Such as (2-(4-(3-(1,4,5,6-Tetrahydropyrimidin-2-ylamino)prop oxy)phenyl) -cyclopropyl)acetic acid; for treating angiogenesis/osteoporosis/ humoral hypercalcemia/smooth muscle cell migration/atherosclerosis/arthritis |
| 07/26/2005 | US6921761 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/26/2005 | CA2324848C Method of making camptothecin and camptothecin analogs |
| 07/26/2005 | CA2234642C 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/26/2005 | CA2112011C Substituted pyridines |
| 07/21/2005 | WO2005066164A1 Opioid receptor antagonists |
| 07/21/2005 | WO2005066159A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005066155A1 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5 |
| 07/21/2005 | WO2005066145A1 Heteroaryl-ureas and their use as glucokinase activators |
| 07/21/2005 | WO2005066130A1 Piperazines useful for treating pain |
| 07/21/2005 | WO2005066129A2 Bis-pyridino containing compounds for use in the treatment of cns pathologies |
| 07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | WO2005065195A2 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/21/2005 | WO2005043124A3 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
| 07/21/2005 | WO2005033119A9 Supramolecular compounds and their use as antitumour and antiviral agents |
| 07/21/2005 | WO2005030979A3 Dark quenchers for fluorescence resonance energy transfer (fret) in bioassays |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | WO2004050609A8 Substituted ureas and carbamates |
| 07/21/2005 | US20050159601 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
| 07/21/2005 | US20050159570 Molecularly imprinted polymer obtainable by polymerization of hexamethyl phosphonamide based monomer in presence of a template molecule and extraction; crosslinking; separation of enantiomers, resolution |
| 07/21/2005 | US20050159459 inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful to reduce forming beta peptides |
| 07/21/2005 | US20050159458 Reacting N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitrile in the presence of an alkali alcoholate base with a 4-(methylsulfonyl)benzyl halogenide; starting with industrially available 2-methyl-5-ethylpyridine; intermediate for preparing COX-2 inhibitors |
| 07/21/2005 | US20050159457 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors |
| 07/21/2005 | US20050159455 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 07/21/2005 | US20050159412 hydroxamic acid and N-formyl hydroxylamine compounds which inhibit the activity of the bacterial enzyme known as peptide deformylase |
| 07/21/2005 | US20050159402 Polyarylcarboxamides useful as lipid lowering agents |
| 07/21/2005 | US20050159363 Selective neuronal nitric oxide synthase inhibitors |
| 07/21/2005 | US20050159314 Converting substituted mono or bicyclic lactones in presence of an amine base and a catalytic amount of a cyanide or alkali or alkaline metal alcoholate, to a salt, reacting the salt with carbonyl compound containing an organic substituent |
| 07/21/2005 | US20050158479 Volatile copper(II) complexes and reducing agents for deposition of copper films by atomic layer deposition |
| 07/21/2005 | US20050158263 Pyrithione biocides enhanced by zinc metal ions and organic amines |
| 07/21/2005 | US20050158240 Method for labeling with tritium |
| 07/21/2005 | US20050156336 Process for exchanging functional groups by halogen-metal exchange reaction |
| 07/21/2005 | CA2552726A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2551862A1 Piperazines useful for treating pain |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | CA2549089A1 Opioid receptor antagonists |
| 07/21/2005 | CA2548849A1 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/21/2005 | CA2548039A1 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5 |
| 07/20/2005 | EP1555269A1 Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device, process for preparing the compounds, and organic electroluminescent device using the compounds |